March 4, 2024
Latest enterprise software release of Genedata Screener increases data quality and accelerates project cycles Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced a new release of Genedata Screener®, its enterprise platform for automated assay data analytics and consolidated assay information management across an enterprise. The new version [...]
March 4, 2024
LEIDEN, NL – Synexa Life Sciences, a global Clinical Laboratory Services provider for the biopharma industry, announces the integration of the Olink® Target immunoassays and the Olink® Signature Q100 instrument into its extensive suite of biomarker discovery platforms.The adoption of Olink Signature Q100 represents a significant step forward in Synexa's commitment to providing leading biomarker [...]
Golden Helix is Launching VSPGx
March 4, 2024
BOZEMAN, Mont. -- Golden Helix, Inc. announces the release of VSPGx, a pharmacogenomics solution for hospitals and testing labs. The field of pharmacogenetics bridges genetics and pharmacology, with the aim of optimizing drug therapies for individual patients based on their unique genetic makeup. It has the potential to revolutionize healthcare by improving drug efficacy, reducing adverse reactions, [...]
March 4, 2024
Shenzhen, China — MGI Tech, a company committed to building core tools and technology to lead life science, today proudly announced a milestone collaboration with Eurofins Genomics Europe Genotyping A/S (“Eurofins Genomics”), which has placed a corporate order of the revolutionary DNBSEQ-T20×2 (“T20”) ultra-high throughput sequencer, along with the genomics data center ZTRON Appliance and [...]
March 4, 2024
We are happy to welcome our new portfolio company Cryocloud! Together with Nina Capital and ROM Utrecht Region we have invested € 500K to help the company in their mission to accelerate protein structure determination. We believe the company holds great promise to expand the use of CryoEM in drug development, with their cloud-based data [...]
Power to see more with improved resolution and light dose balance.
March 4, 2024
Wetzlar, Germany – Leica Microsystems, a leader in microscopy and scientific instrumentation, has revealed TauSTED Xtend, a new STED microscopy approach that enables extended multicolor live cell imaging at nanoscopic resolution. By combining spatial and lifetime information, TauSTED Xtend resolves details of live or intact specimens at nanoscale. At the same time, the access to [...]
Bio-Rad’s dd-Check STEC Solution Receives AOAC International Approval
March 2, 2024
HERCULES, Calif.—Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that AOAC INTERNATIONAL has approved Bio-Rad’s dd-Check STEC Solution for detecting and confirming virulence genes from Shiga toxin-producing Escherichia coli (STEC), in raw beef trim, fresh spinach and carcass sampling cloths. It is the first Droplet [...]
STRmix Team Launches STRmix™ NGS
March 1, 2024
New Expert Forensic Software Enables Users to Investigate Interpretation of Complex Next Generation Sequencing Mixtures The team that created STRmix™ – sophisticated forensic software used to resolve mixed DNA profiles previously thought to be too complex to interpret – is launching STRmix™ NGS (Next Generation Sequencing). NGS, also known as MPS (Massively Parallel Sequencing), is [...]
Bruker Completes Acquisition of Optical Cell Imaging Company Phasefocus
March 1, 2024
BILLERICA, Massachusetts ─ Bruker today announced that it has completed the acquisition of Phasefocus Holdings Limited, which was already announced on December 22nd, 2023. Phasefocus is a privately held company that has leading expertise in imaging and image processing algorithms. Phasefocus has deployed their expertise to develop a novel optical microscope, called Livecyte, for label [...]
February 29, 2024
Shimadzu Corporation acquired the catalytic microreactor business for gas chromatography (GC) from Activated Research Company, LLC (ARC, Minnesota, USA). In the Green Transformation (GX) area, many studies are in progress on the shift towards carbon-neutral (net zero greenhouse gas emissions) through new energy sources, such as hydrogen and biofuels, and on the capture and utilization [...]

